Immuneering Corporation
IMRX
$3.95
-$0.09-2.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.54% | 35.85% | -2.52% | -2.51% | -5.16% |
| Total Depreciation and Amortization | -4.21% | -10.92% | -10.49% | -6.13% | -5.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.45% | -10.37% | -8.50% | -7.02% | 26.52% |
| Change in Net Operating Assets | -607.48% | -95.12% | 306.52% | 353.53% | 66.38% |
| Cash from Operations | -30.91% | 32.18% | 11.10% | 18.04% | 9.11% |
| Capital Expenditure | -797.75% | -1,218.09% | -37.74% | 93.60% | 76.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1,710.84% | -- | -- | -- |
| Cash from Investing | -708,560.67% | -1,715.85% | 99.87% | -100.04% | -100.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.69% | 329.80% | 4,855.02% | -- | 1,309.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -458.44% | -- | -- | -- |
| Cash from Financing | -98.69% | -771.95% | 4,784.57% | -- | 1,309.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29,048.21% | -991.70% | 1,485.45% | -45.00% | -104.05% |